Clinical Edge
- Company typePrivate
- Founded1995
- HeadquartersMilwaukee, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
Clinical Edge firmographics
Firmographics- Name
- Clinical Edge
- Legal name
- OptymEdge, LLC
- Website
- https://clinicaledgeinc.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Clinical Edge industry classification
Industry- Product category
- Ophthalmology Clinical Trial Technology
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)
- akta.pro secondary industry
- Ophthalmology Pharmaceuticals (HLAIAAAL)
Keywords
Where Clinical Edge is headquartered
LocationHeadquarters
- HQ city
- Milwaukee
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Clinical Edge business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Clinical Trial Services: Full-service clinical trial endpoint services including visual function data capture, central imaging, site certification, RBQM, data management, and biostatistics - provided as integrated professional services to pharmaceutical sponsors.
- Integrated Trial Management: End-to-end managed services for ophthalmology trials covering study design through execution, reducing sponsor handoffs and providing unified service delivery.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Clinical Edge product offering
Product offeringCore offering
Clinical Edge (OptymEdge, LLC) provides the Acuvera Suite, an AI-powered platform for ophthalmology clinical trials that unifies visual function data capture (Acuvera Capture), regulatory-ready central imaging services (Acuvera Imaging), and assessment-based site certification (Acuvera Certify). The company offers integrated RBQM, data management, and biostatistics services delivered to pharmaceutical and biotech sponsors running ophthalmology trials globally.
Product overview
OptymEdge is an integrated, AI-powered partner for ophthalmology clinical trials offering the Acuvera Suite as its core platform. The suite unifies three primary modules—Acuvera Capture for visual function data capture, Acuvera Imaging for regulatory-ready central imaging services, and Acuvera Certify for assessment-based certification tracking—combined with RBQM, data management, and biostatistics services. The platform reduces handoffs, improves endpoints, and accelerates trial timelines, backed by 30+ years of ophthalmic expertise.
Differentiator
Problem solved
Functional benefit
Brands
- Acuvera Suite: Integrated platform unifying visual function data capture, imaging, and certification with RBQM, data management, and biostatistics
- Acuvera Capture
- Acuvera Imaging
- Acuvera Certify
Products and services
- Acuvera Suite Unified AI-powered platform for ophthalmology clinical trials that integrates visual function data capture, imaging, and certification services with RBQM, data management, and biostatistics capabilities. Designed for pharmaceutical and biotech sponsors conducting ophthalmology trials.
- Acuvera Capture Visual function data capture platform designed by ophthalmic experts that eliminates paper-based processes, reduces errors, and streamlines data flow with built-in logic and automated calculations. For pharmaceutical sponsors and clinical trial sites running ophthalmology studies.
- Acuvera Imaging Regulatory-ready central imaging service delivering standardized, unbiased grading and advanced quality control, supporting trials from early phase through global multi-center studies. For pharmaceutical and biotech sponsors requiring ophthalmology imaging endpoints.
- Acuvera Certify Assessment-based centrally tracked certification platform enabling faster startup and standardized oversight, powering a data-driven Certified Site Network for ophthalmology clinical trials. For sponsors and trial sites conducting ophthalmology research.
Quantifiable outcome
- Reduces handoffs between data capture, imaging, certification and data management
- +2 more outcomes
Companies that use Clinical Edge
Customer profileSegments1 record
Ideal customer profiles1 record
Clinical Edge technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Clinical Edge partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights4 records
Clinical Edge competitors and assessment
Company assessmentDirect peers
- ProTrials Research: Specialty CRO focused on patient-centric clinical research across multiple therapeutic areas; comparable emerging direct peer competing for similar sponsor RFPs.
- Ora, Inc. Specialty CRO focused exclusively on ophthalmology clinical research, offering endpoint services, central reading, and clinical trial management — directly comparable to OptymEdge's Acuvera Suite.
Broad incumbents
- IQVIA: Largest global CRO with deep ophthalmology and imaging reading-center capabilities; competes with OptymEdge for visual function endpoint and central imaging work.
- Medpace: Mid-to-large full-service CRO with active ophthalmology franchise; competes for sponsor trial mandates alongside OptymEdge's specialty services.
- Clario: Major clinical trial endpoint and eCOA/imaging services provider; competes with Acuvera Imaging and Capture as a large incumbent offering digital endpoint solutions across many therapeutic areas including ophthalmology.
- Signant Health: Provides eCOA and clinical technology including visual function assessments used in ophthalmology trials; comparable to OptymEdge's Acuvera Capture as a broader endpoint technology vendor.
- ICON plc: Top-5 global CRO offering full-service ophthalmology clinical trial capabilities including imaging and data capture; competes for the same pharma sponsors as OptymEdge.
- Worldwide Clinical Trials: Mid-sized CRO with strong CNS and specialty therapeutic expertise; competes in adjacent outsourced trial services for biotech and pharma sponsors.
- Charles River Laboratories: Global CRO/CDMO with significant ophthalmology preclinical and clinical services, comparable as a diversified scientific services competitor for sponsor-funded work.
Others
- The Emmes Group: Larger CRO umbrella that OptymEdge is affiliated with (per footer references); comparable as parent/affiliated CRO offering integrated trial services and endpoint support across multiple therapeutic areas.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Clinical Edge social profiles
Digital presenceClinical Edge financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clinical Edge leadership team
Management profileNumber of profiles
Clinical Edge funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clinical Edge M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clinical Edge
What does Clinical Edge do?
Clinical Edge (OptymEdge, LLC) provides the Acuvera Suite, an AI-powered platform for ophthalmology clinical trials that unifies visual function data capture (Acuvera Capture), regulatory-ready central imaging services (Acuvera Imaging), and assessment-based site certification (Acuvera Certify). The company offers integrated RBQM, data management, and biostatistics services delivered to pharmaceutical and biotech sponsors running ophthalmology trials globally.
Is Clinical Edge a public or private company?
Clinical Edge is a private company. It is classified as corporate owned and is currently operating.
When was Clinical Edge founded?
Clinical Edge was founded in 1995. It employs 101 to 250 people.
Where is Clinical Edge based?
Clinical Edge is headquartered in Milwaukee, United States, in the North America region.
How does Clinical Edge make money?
Two revenue lines are on record. Clinical Trial Services are the primary driver. The others are integrated Trial Management.
Who are Clinical Edge's main competitors?
Direct peers on record are ProTrials Research and Ora, Inc.. Broad incumbents are IQVIA, Medpace, Clario, Signant Health, ICON plc, Worldwide Clinical Trials and Charles River Laboratories. The Emmes Group is listed as an others.
Does Clinical Edge have an API?
No public API is recorded for Clinical Edge.
What industry is Clinical Edge in?
Clinical Edge's product category is Ophthalmology Clinical Trial Technology. Its primary akta.pro industry code is HLAKAKAN, Ocular Imaging & Diagnostic Testing Centers, with a secondary code of HLAIAAAL, Ophthalmology Pharmaceuticals. Its NAICS code is 5417 and its SIC code is 8731.